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1. Introduction
  Diabetes is a global disease with rapid increase in both 
developed and developing countries[1], especially in China. 
Hyperglycemia is one remarkable feature of diabetes 
patients. As an important indicator of long-term blood 
glucose control, glycosylated hemoglobin(HbA1c) can reflect 
cumulative blood glucose for 2-3 months[2]. Diabetes 
Complications and Control Trial has established HbA1c as 
the gold standard for glycemic control, and proposes HbA1c 
at 曑7% as critical value for reducing the risk of vascular 
complications[3]. Elevated HbA1c has been regarded as an 
independent risk factor for coronary heart disease(CHD) 
in patients with or without diabetes[4]. Ravipati et al[5] also 
observed a direct correlation between HbA1c concentration 
and the severity of coronary artery disease (CAD) in diabetic 
patients. 
  It is reported that most patients with type 2 diabetes could 
have dyslipidemia at varying degrees, characterized by 
increased levels of TG and LDL-C and decreased HDL-C. 
Giansanti et al[6] also observed significantly higher levels of 
hypercholesterolemia and hyperlipidemia in type 2 diabetic 
patients with cardiovascular disease(CVD) compared to 
diabetic patients without CVD, which may elevate the 
mortality rate of these patients[7]. At recent years, more data 
support that the lipid ratio is more sensitive in reflecting 
the morbidity and severity of CHD than individual lipid[8,9]. 
However, little is known about the relationship between 
hyperglycemia and lipid ratio levels in type 2 diabetes 
mellitus (T2DM) patients.
  In this study, we examined the correlation between the 
severity of glucose intolerance, which was reflected by 
HbA1c level, and blood lipid ratio & individual lipid, to 
evaluate which is the most sensitive in predicting risk and 
severity of CVD in T2DM patients.
Objective:  To study the correlation of lipid ratios and individual lipid indexes of patients with 
type 2 diabetes with glycosylated hemoglobin (HbA1c). Methods: Samples were collected from 
128 type 2 diabetic patients (aged 19-90 years; male 72, female 56). The sera were analyzed for 
HbA1c, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) 
and low-density lipoprotein cholesterol (LDL-C). According to the HbA1c level, the patients were 
divided into three groups, group A (HbA1c <7%, n=31), group B (7%曑HbA1c曑10%, n=48), and 
group C (HbA1c >10%, n=49). The correlation of HbA1c with lipid ratios & individual lipid indexes 
were analyzed. Results: With the increased level of HbA1c, LDL-C had a significantly increasing 
trend (P<0.05); whereas TC went up with the increased HbA1c, without any significant differences 
between three groups. There was no significant correlation between HbA1c and TG or HDL-C. 
With the increased level of HbA1c, TC/HDL-C, LDL-C/HDL-C ratios were gradually increased, 
with significant differences among groups (P<0.05). The lipid ratios, especially LDL-C/HDL-C 
ratio was more susceptible to impaired lipid metabolism in T2DM patients than individual lipid. 
Conclusions: LDL-C/HDL-C ratio is helpful in assessing and reducing the risk of cardiovascular 
disease caused by impaired lipid metabolism in type 2 diabetic patients.
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2. Materials and methods
2.1. Objects
  A total of 128 patients with T2DM admitted during January 
2010 to July 2010 to our hospital were selected, aged 19-90 
years old [(60.05±14.58) yrs], including male 72 and female 
56. All patients underwent oral glucose tolerance test + 
insulin release test and were diagnosed as T2DM. All of them 
had no lipid-controlled drug in recent three months.
2.2. Methods and groups
 Venous blood samples were collected after at least 8 h 
fasting. The sera were analyzed for HbA1c, total cholesterol 
(TC), triglycerides (TG), high-density lipoprotein cholesterol 
(HDL-C) and low-density lipoprotein cholesterol (LDL-C). 
HbA1c was measured by micro-column chromatography, 
TC and TG by enzymatic method, HDL-C and LDL-C by the 
direct method. TG/HDL-C, TC/HDL-C, LDL-C/HDL-C ratios 
were calculated, respectively. All patients were categorized 
into 3 groups according to their HbA1c level: group A (HbA1c 
<7%, n=31), group B (7%曑HbA1c曑10%, n=48), and group 
C (HbA1c >10%, n=49). The correlation of lipid ratios and 
individual lipid indexes among three groups were analyzed.
2.3. Statistic analysis
  The data was analyzed by SPSS16.0 statistical software. 
Data are expressed as the mean暲SD. The relation of HbA1c 
and various blood lipid parameters was evaluated by one-
way analysis of variance (ANOVA). P <0.05 was considered 
as statistically significant.
3. Results
3.1. Correlations between blood individual lipid indexes and 
HbA1c
  TC was gradually increased as increasing HbA1c; however, 
there was no significant correlation between TC and HbA1c 
(Table 1) (F=2.738, P=0.069). LDL-C was increased as 
increasing HbA1c, and there was a significant correlation 
between HbA1c and LDL-C (F=4.300, P=0.016). HbA1c did not 
show any significant correlation with TG (F=1.133, P=0.325), 
or HDL-C (F=1.827, P=0.165).
3.2. Correlations between blood lipid ratio and HbA1c
  HbA1c and TG/HDL-C ratio did not show any significant 
correlation with HbA1c (Table 2) (F=1.213, P=0.301). With 
the increased level of HbA1c, TC/HDL-C and LDL-C/HDL-C 
ratio showed a definite increasing trend, and there was a 
significant correlation between HbA1c and TC/HDL-C ratio 
(F=3.326, P=0.039). LDL-C/HDL-C ratio was also gradually 
increased which had significant correlation with HbA1c 
(F=6.284, P=0.003). The lipid ratios, especially LDL-C/HDL-C 
ratio was more susceptible to impaired lipid metabolism in 
T2DM patients than individual lipid.
4. Discussion
  We observed significant correlation between HbA1c and 
LDL-C in diabetic patients, which is in agreement with the 
findings of several other investigators who also reported 
significant correlations between HbA1c and individual 
blood lipid[10,11]. However, we did not observe significant 
correlation of HbA1c with TG, TC or HDL-C. Diabetic patients 
with poor glycaemic control exhibited a significant increase 
in TC/HDL-C and LDL-C/HDL-C ratios, especially in LDL-C/
HDL-C ratios. The result of this study clearly showed that 
the control of impaired glycaemic which is defined by HbA1c 
was proportionally related with degree of dyslipidemia, 
including LDL-C, TC/HDL-C and LDL-C/HDL-C ratios, 
especially LDL-C/HDL-C ratio. The reason maybe because 
that the change of ratios is earlier than individual lipid, 
especially in patients with normal blood lipid.     
  CVD is the main cause for mortality and disability in 
individuals older than 65 years, despite the progressive 
decline in the incidence of CVD since 1970s[12]. Therefore, 
prevention of CVD is essential[13]. It is reported that T2MD 
patients had increased susceptibility to vascular disease 
Table 1 
Correlations between blood individual lipid indexes and HbA1c.
Group TG(mmol/L) TC(mmol/L) HDL-C(mmol/L) LDL-C(mmol/L)
A 1.64暲1.26 4.25暲1.20 1.32暲0.52 2.23暲0.99
B 1.62暲0.80 4.43暲1.47 1.15暲0.31 2.77暲1.15
C 2.01暲1.87 4.91暲1.31 1.24暲0.39 2.98暲1.16
Table 2 
Correlations between blood lipid ratio and HbA1c.
Group TG/HDL-C TC/HDL-C LDL-C/HDL-C
A 1.57暲1.49 3.47暲1.22 1.81暲0.89
B 1.50暲0.83 4.03暲1.06 2.47暲0.83
C 2.02暲2.42 4.23暲1.52 2.54暲1.09
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associated with LDL-C[14]. To the contrary, Cardenas et al[15] 
found that HDL-C level was a major and independent risk 
factor, and had more relationship with the development 
of CAD than total cholesterol and LDL-C level. Elizabete 
et al[16] also reported that low HDL-C was a risk factor for 
CVD of the elder, whereas LDL-C showed no significant 
association with the development of CVD. 
  In recent, more data support that lipid ratio is more 
sensitive in reflecting the morbidity and severity of 
CHD than individual lipid[8,9]. Blood lipid ratio is more 
meaningful than individual blood lipid level in judging 
the severity of CAD[17]. Pan et al[18] showed lipid ratio is 
more meaningful in the early prevention and diagnosis of 
CHD than the individual serum lipids. LDL-C/HDL-C ratio 
is increased more obviously than other lipid indicators in 
T2DM patientscomplicated with CAD[19]. Shai et al[8] reported 
TC/HDL-C, LDL-C/HDL-C and apo B/apo A ratios are more 
susceptible to increased cardiovascular mortality than 
individual blood lipid, and they deemed that ratios have the 
effect of inducible-arteriosclerosis and anti-arteriosclerosis. 
In conclusion, most patients with type 2 diabetes have 
dyslipidemia to varying degrees. With the increased levels 
of HbA1c, dyslipidemia become more severe. Compared 
with individual lipid indexes, the changes of lipid ratio can 
reflect impaired lipid metabolism at earlier stage, and the 
most sensitive indicator is LDL-C/HDL-C ratio. Thus, LDL-C/
HDL-C ratio is helpful in assessing and reducing the risk of 
cardiovascular disease due to impaired lipid metabolism in 
type 2 diabetic patients.
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